Commercialization

sarepta building

Fierce Pharma

FDA backtracks on Sarepta's gene therapy Elevidys in DMD

The agency said that it had concluded that the death of an 8-year-old was not related to Elevidys but addressed none of the three prior deaths.

Angus Liu Jul 28, 2025 6:02pm

Cartoon of businessmen standing around a broken target

Outlook lays off 23% of staff as it eyes FDA approval, EU debut

Dec 16, 2024 8:25am

Dicerna CEO Douglas Fambrough

Dicerna wants partner to sell nedosiran

Aug 10, 2021 8:00am

Parachute

Epizyme CEO Bazemore passes the baton for 'next phase of growth'

Aug 9, 2021 10:44am

ABC Article 4 primary commercialization

Leveraging Data and Real-World Evidence to Drive Product Success

May 17, 2021 9:00am

Gloved hands putting together a liver out of puzzle pieces

Arrowhead, Takeda's RNAi med cuts scarring in rare liver disease

Apr 28, 2021 2:59pm